These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37345887)

  • 1. Rituximab for the treatment of epidermolysis bullosa acquisita: A large case series of 15 patients.
    Dasdar S; Kianfar N; Tavakolpour S; Balighi K; Mahmoudi H; Daneshpazhooh M
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):779-784. PubMed ID: 37345887
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermolysis bullosa acquisita treated with rituximab.
    Mendes SR; Coutinho I; Cardoso JC
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34257124
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab.
    Gordilho JO; Miyamoto D; Maruta CW; Santo RM; Mahmoud A; Navarro-Rodriguez T; Werneck-Silva AL; de Aguiar LM; Borges IC; Santi CG; Aoki V
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e45-e47. PubMed ID: 37565448
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of rituximab in treatment of epidermolysis bullosa acquisita: Three new cases and a review of the literature.
    Bevans SL; Sami N
    Dermatol Ther; 2018 Nov; 31(6):e12726. PubMed ID: 30284354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case Report of the Use of Rituximab and the Epidermolysis Bullosa Disease Activity Scoring Index (EBDASI) in a Patient with Epidermolysis Bullosa Acquisita with Extensive Esophageal Involvement.
    Yang A; Kim M; Craig P; Murrell DF
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):325-328. PubMed ID: 30665483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermolysis bullosa acquisita: a case series of three paediatric patients.
    Bageta ML; Cella E; Cervini AB; Centeno MDV; Roquel L; Mee JB; Groves RW; Calonje E; Goodwin RG; Mellerio JE; Petrof G; Martinez AE
    Clin Exp Dermatol; 2022 Jul; 47(7):1346-1349. PubMed ID: 35080258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Recurrent Epidermolysis Bullosa Acquisita With Tofacitinib.
    Fan B; Wang M
    JAMA Dermatol; 2023 Mar; 159(3):342-344. PubMed ID: 36753196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.
    Wallet-Faber N; Franck N; Batteux F; Mateus C; Gilbert D; Carlotti A; Avril MF; Dupin N
    Dermatology; 2007; 215(3):252-5. PubMed ID: 17823525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained clinical remission for 5 years in severe epidermolysis bullosa acquisita following rituximab infusions.
    Koszegi B; Stone C; Ishii N; Hashimoto T; Murrell DF
    J Eur Acad Dermatol Venereol; 2024 Sep; 38(9):e747-e749. PubMed ID: 38357844
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of recalcitrant epidermolysis bullosa acquisita responsive to rituximab therapy.
    McKinley SK; Huang JT; Tan J; Kroshinsky D; Gellis S
    Pediatr Dermatol; 2014; 31(2):241-4. PubMed ID: 23106762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermolysis bullosa acquisita in a 17-year-old boy with Crohn's disease.
    Russo I; Ferrazzi A; Zanetti I; Alaibac M
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26163555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory epidermolysis bullosa acquisita: successful treatment with rituximab.
    Saha M; Cutler T; Bhogal B; Black MM; Groves RW
    Clin Exp Dermatol; 2009 Dec; 34(8):e979-80. PubMed ID: 20055876
    [No Abstract]   [Full Text] [Related]  

  • 13. From the Cochrane Library: Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita.
    Sprague KA; Sivesind TE; Szeto MD; Dellavalle RP; Kirtschig G
    J Am Acad Dermatol; 2022 Jun; 86(6):e273-e274. PubMed ID: 35176396
    [No Abstract]   [Full Text] [Related]  

  • 14. Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients.
    Iwata H; Vorobyev A; Koga H; Recke A; Zillikens D; Prost-Squarcioni C; Ishii N; Hashimoto T; Ludwig RJ
    Orphanet J Rare Dis; 2018 Sep; 13(1):153. PubMed ID: 30180870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy.
    Oktem A; Akay BN; Boyvat A; Kundakci N; Erdem C; Bostancı S; Sanli H; Kocyigit P
    J Dermatolog Treat; 2017 Feb; 28(1):50-54. PubMed ID: 27161164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidermolysis bullosa acquisita and hepatitis C].
    Thiery S; Misery L; Chossegros P; Kanitakis J; Ghohestani R; Forestier JY; Trepo C; Faure M; Claudy A
    Ann Dermatol Venereol; 1998 Apr; 125(4):264-7. PubMed ID: 9747265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermolysis bullosa acquisita.
    Miyamoto D; Gordilho JO; Santi CG; Porro AM
    An Bras Dermatol; 2022; 97(4):409-423. PubMed ID: 35701269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab.
    Sadler E; Schafleitner B; Lanschuetzer C; Laimer M; Pohla-Gubo G; Hametner R; Hintner H; Bauer JW
    Br J Dermatol; 2007 Aug; 157(2):417-9. PubMed ID: 17596155
    [No Abstract]   [Full Text] [Related]  

  • 19. A rare occurrence of epidermolysis bullosa acquisita in a patient with retroviral disease.
    Uddhao Z; Aditi C; Chitra N; Swagata T
    Int J STD AIDS; 2017 Oct; 28(12):1255-1258. PubMed ID: 28632473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermolysis bullosa acquisita.
    ORFUSS AJ
    AMA Arch Derm Syphilol; 1951 Dec; 64(6):794. PubMed ID: 14867924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.